{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:32:53Z","timestamp":1791142373377,"version":"4.1.0"},"reference-count":48,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Several strategies that target anthrax toxin are being developed as therapies for infection by\n            <jats:italic>Bacillus anthracis<\/jats:italic>\n            . Although the action of the tripartite anthrax toxin has been extensively studied in vitro, relatively little is known about the presence of toxins during an infection in vivo. We developed a series of sensitive sandwich enzyme-linked immunosorbent assays (ELISAs) for detection of both the protective antigen (PA) and lethal factor (LF) components of the anthrax exotoxin in serum. The assays utilize as capture agents an engineered high-affinity antibody to PA, a soluble form of the extracellular domain of the anthrax toxin receptor (ANTXR2\/CMG2), or PA itself. Sandwich immunoassays were used to detect and quantify PA and LF in animals infected with the Ames or Vollum strains of anthrax spores. PA and LF were detected before and after signs of toxemia were observed, with increasing levels reported in the late stages of the infection. These results represent the detection of free PA and LF by ELISA in the systemic circulation of two animal models exposed to either of the two fully virulent strains of anthrax. Simple anthrax toxin detection ELISAs could prove useful in the evaluation of potential therapies and possibly as a clinical diagnostic to complement other strategies for the rapid identification of\n            <jats:italic>B. anthracis<\/jats:italic>\n            infection.\n          <\/jats:p>","DOI":"10.1128\/cvi.00023-06","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T17:07:13Z","timestamp":1149700033000},"page":"671-677","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":110,"title":["Detection of Anthrax Toxin in the Serum of Animals Infected with\n            <i>Bacillus anthracis<\/i>\n            by Using Engineered Immunoassays"],"prefix":"10.1128","volume":"13","author":[{"given":"Robert","family":"Mabry","sequence":"first","affiliation":[{"name":"Institute for Cellular and Molecular Biology, University of Texas at Austin, Texas"},{"name":"Department of Comparative Medicine, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Chemical Engineering and Biomedical Engineering, University of Texas at Austin, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Brasky","sequence":"additional","affiliation":[{"name":"Institute for Cellular and Molecular Biology, University of Texas at Austin, Texas"},{"name":"Department of Comparative Medicine, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Chemical Engineering and Biomedical Engineering, University of Texas at Austin, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Geiger","sequence":"additional","affiliation":[{"name":"Institute for Cellular and Molecular Biology, University of Texas at Austin, Texas"},{"name":"Department of Comparative Medicine, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Chemical Engineering and Biomedical Engineering, University of Texas at Austin, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ricardo","family":"Carrion","sequence":"additional","affiliation":[{"name":"Institute for Cellular and Molecular Biology, University of Texas at Austin, Texas"},{"name":"Department of Comparative Medicine, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Chemical Engineering and Biomedical Engineering, University of Texas at Austin, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene B.","family":"Hubbard","sequence":"additional","affiliation":[{"name":"Institute for Cellular and Molecular Biology, University of Texas at Austin, Texas"},{"name":"Department of Comparative Medicine, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Chemical Engineering and Biomedical Engineering, University of Texas at Austin, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Leppla","sequence":"additional","affiliation":[{"name":"Institute for Cellular and Molecular Biology, University of Texas at Austin, Texas"},{"name":"Department of Comparative Medicine, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Chemical Engineering and Biomedical Engineering, University of Texas at Austin, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Patterson","sequence":"additional","affiliation":[{"name":"Institute for Cellular and Molecular Biology, University of Texas at Austin, Texas"},{"name":"Department of Comparative Medicine, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Chemical Engineering and Biomedical Engineering, University of Texas at Austin, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Georgiou","sequence":"additional","affiliation":[{"name":"Institute for Cellular and Molecular Biology, University of Texas at Austin, Texas"},{"name":"Department of Comparative Medicine, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Chemical Engineering and Biomedical Engineering, University of Texas at Austin, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. L.","family":"Iverson","sequence":"additional","affiliation":[{"name":"Institute for Cellular and Molecular Biology, University of Texas at Austin, Texas"},{"name":"Department of Comparative Medicine, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, Texas"},{"name":"Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Chemical Engineering and Biomedical Engineering, University of Texas at Austin, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1083\/jcb.200211018","volume":"160","year":"2003","unstructured":"Abrami, L., S. Liu, P. Cosson, S. H. Leppla, and F. G. van der Goot. 2003. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol.160:321-328.","journal-title":"J. Cell Biol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature01794","volume":"424","year":"2003","unstructured":"Agrawal, A., J. Lingappa, S. H. Leppla, S. Agrawal, A. Jabbar, C. Quinn, and B. Pulendran. 2003. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature424:329-334.","journal-title":"Nature"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.11.6231-6241.2002"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.287.7.863","volume":"287","year":"2002","unstructured":"Barakat, L. A., H. L. Quentzel, J. A. Jernigan, D. L. Kirschk, K. Griffith, S. M. Spear, K. Kelley, D. Barden, D. Mayo, D. S. Stephens, T. Popovic, C. Marston, S. R. Zaki, J. Guarner, W. J. Shieh, R. F. Meyer, D. L. Swerdlow, E. E. Mast, J. L. Hadle, et al. 2002. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA287:863-868.","journal-title":"JAMA"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1462-5822.2000.00052.x","volume":"2","year":"2000","unstructured":"Beauregard, K. E., R. J. Collier, and J. A. Swanson. 2000. Proteolytic activation of receptor-bound anthrax protective antigen on macrophages promotes its internalization. Cell. Microbiol.2:251-258.","journal-title":"Cell. Microbiol."},{"key":"e_1_3_2_7_2","first-page":"167G","year":"2004","unstructured":"Beebe, L., M. Babin, R. Barnewall, J. Zhong, and G. Choi. 2004. Post-exposure therapeutic potential of PAmAb in an inhalation model of anthrax in New Zealand white rabbits (NZW), abstr. 167G. In Abstr. 2004 Am. Soc. Microbiol. Biodefense Res. Meet. (Baltimore). American Society for Microbiology, Washington, D.C.","journal-title":"Am. Soc. Microbiol. Biodefense Res. Meet. (Baltimore)"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","volume":"414","year":"2001","unstructured":"Bradley, K. A., J. Mogridge, M. Mourez, R. J. Collier, and J. A. Young. 2001. Identification of the cellular receptor for anthrax toxin. Nature414:225-229.","journal-title":"Nature"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/sim.2033","volume":"24","year":"2005","unstructured":"Brookmeyer, R., E. Johnson, and S. Barry. 2005. Modeling the incubation period of anthrax. Stat. Med.24:531-542.","journal-title":"Stat. Med."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-2958.1990.tb00685.x","volume":"4","year":"1990","unstructured":"Cataldi, A., E. Labruyere, and M. Mock. 1990. Construction and characterization of a protective antigen-deficient Bacillus anthracis strain. Mol. Microbiol.4:1111-1117.","journal-title":"Mol. Microbiol."},{"key":"e_1_3_2_11_2","first-page":"937","volume":"52","year":"2003","unstructured":"Centers for Disease Control and Prevention. 2003. Follow-up of deaths among U.S. Postal Service workers potentially exposed to Bacillus anthracis\u2014District of Columbia, 2001-2002. Morb. Mortal. Wkly. Rep.52:937-938.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","volume":"19","year":"2003","unstructured":"Collier, R. J., and J. A. Young. 2003. Anthrax toxin. Annu. Rev. Cell Dev. Biol.19:45-70.","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3201\/eid0810.020392","volume":"8","year":"2002","unstructured":"De, B. K., S. L. Bragg, G. N. Sanden, K. E. Wilson, L. A. Diem, C. K. Marston, A. R. Hoffmaster, G. A. Barnett, R. S. Weyant, T. G. Abshire, J. W. Ezzell, and T. Popovic. 2002. A two-component direct fluorescent-antibody assay for rapid identification of Bacillus anthracis. Emerg. Infect. Dis.8:1060-1065.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","volume":"280","year":"1998","unstructured":"Duesbery, N. S., C. P. Webb, S. H. Leppla, V. M. Gordon, K. R. Klimpel, T. D. Copeland, N. G. Ahn, M. K. Oskarsson, K. Fukasawa, K. D. Paull, and G. F. Vande Woude. 1998. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science280:734-737.","journal-title":"Science"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1021\/bi000310u","volume":"39","year":"2000","unstructured":"Elliott, J. L., J. Mogridge, and R. J. Collier. 2000. A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen. Biochemistry39:6706-6713.","journal-title":"Biochemistry"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1099\/00221287-138-3-543","volume":"138","year":"1992","unstructured":"Ezzell, J. W., Jr., and T. G. Abshire. 1992. Serum protease cleavage of Bacillus anthracis protective antigen. J. Gen. Microbiol.138:543-549.","journal-title":"J. Gen. Microbiol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1073\/pnas.0502733102","volume":"102","year":"2005","unstructured":"Forino, M., S. Johnson, T. Y. Wong, D. V. Rozanov, A. Y. Savinov, W. Li, R. Fattorusso, B. Becattini, A. J. Orry, D. Jung, R. A. Abagyan, J. W. Smith, K. Alibek, R. C. Liddington, A. Y. Strongin, and M. Pellechia. 2005. Efficient synthetic inhibitors of anthrax lethal factor. Proc. Natl. Acad. Sci. USA102:9499-9504.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1462-5822.2000.00057.x","volume":"2","year":"2000","unstructured":"Guidi-Rontani, C., M. Weber-Levy, M. Mock, and V. Cabiaux. 2000. Translocation of Bacillus anthracis lethal and oedema factors across endosome membranes. Cell. Microbiol.2:259-264.","journal-title":"Cell. Microbiol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1091\/mbc.3.11.1269","volume":"3","year":"1992","unstructured":"Hanna, P. C., S. Kochi, and R. J. Collier. 1992. Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Mol. Biol. Cell3:1269-1277.","journal-title":"Mol. Biol. Cell"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1073\/pnas.0400187101","volume":"101","year":"2004","unstructured":"Harvey, B. R., G. Georgiou, A. Hayhurst, K. J. Jeong, B. L. Iverson, and G. K. Rogers. 2004. Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries. Proc. Natl. Acad. Sci. USA101:9193-9198.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-1759(03)00100-5","volume":"276","year":"2003","unstructured":"Hayhurst, A., S. Happe, R. Mabry, Z. Koch, B. L. Iverson, and G. Georgiou. 2003. Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis. J. Immunol. Methods276:185-196.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1006\/prep.1999.1035","volume":"15","year":"1999","unstructured":"Hayhurst, A., and W. J. Harris. 1999. Escherichia coli skp chaperone coexpression improves solubility and phage display of single-chain antibody fragments. Protein Expr. Purif.15:336-343.","journal-title":"Protein Expr. Purif."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1021\/jm040139a","volume":"47","year":"2004","unstructured":"Hicks, R. P., A. K. Bhattacharjee, B. W. Koser, and D. D. Traficante. 2004. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding lethal factor to PA63: as determined by trNOESY NMR and molecular modeling. J. Med. Chem.47:5347-5355.","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","volume":"7","year":"2001","unstructured":"Jernigan, J. A., D. S. Stephens, D. A. Ashford, C. Omenaca, M. S. Topiel, M. Galbraith, M. Tapper, T. L. Fisk, S. Zaki, T. Popovic, R. F. Meyer, C. P. Quinn, S. A. Harper, S. K. Fridkin, J. J. Sejvar, C. W. Shepard, M. McConnell, J. Guarner, W. J. Shieh, J. M. Malecki, J. L. Gerberding, J. M. Hughes, B. A. Perkins, et al. 2001. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis.7:933-944.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1073\/pnas.89.21.10277","volume":"89","year":"1992","unstructured":"Klimpel, K. R., S. S. Molloy, G. Thomas, and S. H. Leppla. 1992. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc. Natl. Acad. Sci. USA89:10277-10281.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1073\/pnas.0401351101","volume":"101","year":"2004","unstructured":"Kozel, T. R., W. J. Murphy, S. Brandt, B. R. Blazar, J. A. Lovchik, P. Thorkildson, A. Percival, and C. R. Lyons. 2004. mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proc. Natl. Acad. Sci. USA101:5042-5047.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jmb.2004.09.067","volume":"344","year":"2004","unstructured":"Krantz, B. A., A. D. Trivedi, K. Cunningham, K. A. Christensen, and R. J. Collier. 2004. Acid-induced unfolding of the amino-terminal domains of the lethal and edema factors of the anthrax toxin. J. Mol. Biol.344:739-756.","journal-title":"J. Mol. Biol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.chembiol.2004.05.020","volume":"11","year":"2004","unstructured":"Lee, Y. S., P. Bergson, W. S. He, M. Mrksich, and W. J. Tang. 2004. Discovery of a small molecule that inhibits the interaction of anthrax edema factor with its cellular activator, calmodulin. Chem. Biol.11:1139-1146.","journal-title":"Chem. Biol."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.12.5171-5175.1997"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.7.1807-1813.1988"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.12.8362-8368.2005"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.3.547-551.1993"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mib.2003.12.001","volume":"7","year":"2004","unstructured":"Moayeri, M., and S. H. Leppla. 2004. The roles of anthrax toxin in pathogenesis. Curr. Opin. Microbiol.7:19-24.","journal-title":"Curr. Opin. Microbiol."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1073\/pnas.052160199","volume":"99","year":"2002","unstructured":"Mogridge, J., K. Cunningham, D. B. Lacy, M. Muorez, and R. J. Collier. 2002. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. Proc. Natl. Acad. Sci. USA99:7045-7048.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.2.795-802.2005"},{"key":"e_1_3_2_36_2","first-page":"213","volume":"261","year":"2004","unstructured":"Muorez, M., and R. J. Collier. 2004. Use of phage display and polyvalency to design inhibitors of protein-protein interactions. Methods Mol. Biol.261:213-228.","journal-title":"Methods Mol. Biol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nbt1001-958","volume":"19","year":"2001","unstructured":"Mourez, M., R. S. Kane, J. Mogridge, S. Metallo, P. Deschatelets, B. R. Sellman, G. M. Whitesides, and R. J. Collier. 2001. Designing a polyvalent inhibitor of anthrax toxin. Nat. Biotechnol.19:958-961.","journal-title":"Nat. Biotechnol."},{"key":"e_1_3_2_38_2","first-page":"10834","volume":"380","year":"2005","unstructured":"Panchal, R. G., K. M. Halverson, W. Ribot, D. Lane, T. Kenny, T. G. Abshire, J. W. Ezzell, T. A. Hoover, B. Powell, S. F. Little, J. J. Kasianowicz, and S. Bavari. 2005. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity. J. Biol. Chem.380:10834-10839.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nsmb711","volume":"11","year":"2004","unstructured":"Panchal, R. G., A. R. Hermone, T. L. Nguyen, T. Y. Wong, R. Schwarzenbacher, J. Schmidt, D. Lane, C. McGrath, B. E. Turk, J. Burnett, M. J. Aman, S. Little, E. A. Sausville, D. W. Zaharevitz, L. C. Cantley, R. C. Liddington, R. Gussio, and S. Bavari. 2004. Identification of small molecule inhibitors of anthrax lethal factor. Nat. Struct. Mol. Biol.11:67-72.","journal-title":"Nat. Struct. Mol. Biol."},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"30936","DOI":"10.1074\/jbc.M301154200","volume":"278","year":"2003","unstructured":"Rosovitz, M. J., P. Schuck, M. Varughese, A. P. Chopra, V. Mehra, Y. Singh, L. M. McGinnis, and S. H. Leppla. 2003. Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody. J. Biol. Chem.278:30936-30944.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ab.2005.01.030","volume":"339","year":"2005","unstructured":"Rucker, V. C., K. L. Havenstrute, and A. E. Herr. 2005. Antibody microarrays for native toxin detection. Anal. Biochem.339:262-270.","journal-title":"Anal. Biochem."},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02763","volume":"430","year":"2004","unstructured":"Santelli, E., L. A. Bankston, S. H. Leppla, and R. C. Liddington. 2004. Crystal structure of a complex between anthrax toxin and its host cell receptor. Nature430:905-908.","journal-title":"Nature"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","volume":"100","year":"2003","unstructured":"Scobie, H. M., G. J. Rainey, K. A. Bradley, and J. A. Young. 2003. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA100:5170-5174. [Epub ahead of print.]","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1126\/science.109563","volume":"292","year":"2001","unstructured":"Sellman, B. R., M. Mourez, and R. J. Collier. 2001. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax. Science292:695-697.","journal-title":"Science"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1073\/pnas.0502159102","volume":"102","year":"2005","unstructured":"Shoop, W. L., Y. Xiong, J. Wiltsie, A. Woods, J. Guo, J. V. Pivnichny, T. Felcetto, B. F. Michael, A. Bansal, R. T. Cummings, B. R. Cunningham, A. M. Friedlander, C. M. Douglas, S. B. Patel, D. Wisniewski, G. Scapin, S. P. Salowe, D. M. Zaller, K. T. Chapman, E. M. Scolnick, D. M. Schmatz, K. Bartizal, M. Maccoss, and J. D. Hermes. 2005. Anthrax lethal factor inhibition. Proc. Natl. Acad. Sci. USA102:7958-7963.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.4.1853-1859.1999"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-1759(00)00238-6","volume":"243","year":"2000","unstructured":"Vignali, D. A. 2000. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods243:243-255.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"23349","DOI":"10.1074\/jbc.M401292200","volume":"279","year":"2004","unstructured":"Wigelsworth, D. J., B. A. Krantz, K. A. Christensen, D. B. Lacy, S. J. Juris, and R. J. Collier. 2004. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. J. Biol. Chem.279:23349-23356.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_49_2","first-page":"982","volume":"122","year":"1998","unstructured":"Zaucha, G. M., L. M. Pitt, J. Estep, B. E. Ivins, and A. M. Friedlander. 1998. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch. Pathol. Lab. Med.122:982-992.","journal-title":"Arch. Pathol. Lab. Med."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00023-06","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00023-06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T15:53:38Z","timestamp":1627574018000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00023-06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1128\/CVI.00023-06"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00023-06","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"2005-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2006-04-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}